## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (48% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($275.78)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Copeland Capital Management LLC Boosts Stake in FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251230T101419 | Neutral | Relevance: 100%
- Copeland Capital Management LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS) by 24.6% to 72,369 shares, valued at approximately $20.73 million. Despite the company beating quarterly expectations with EPS of $4.51 and revenue of $607.6 million, and authorizing a $600 million share buyback, the consensus analyst rating remains "Reduce" with a target price of $313.17. FactSet also offers a quarterly dividend of $1.10, yielding about 1.5%, and has seen recent insider stock purchases.

**2. Boston Trust Walden Corp Sells 7,189 Shares of FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251229T100810 | Somewhat-Bullish | Relevance: 100%
- Boston Trust Walden Corp reduced its stake in FactSet Research Systems Inc. ($FDS) by 2.4%, selling 7,189 shares and now holding 290,323 shares valued at approximately $83.18 million. FactSet exceeded earnings expectations with $4.51 EPS and set a robust FY 2026 guidance, while also authorizing a $600 million share buyback and maintaining a $1.10 quarterly dividend. The company currently holds a "Reduce" consensus rating from analysts with a $313.17 price target.

**3. PineStone Asset Management Inc. Purchases 39,025 Shares of FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251228T125613 | Neutral | Relevance: 96%
- PineStone Asset Management Inc. increased its stake in FactSet Research Systems Inc. (NYSE:FDS) by 10.3%, acquiring an additional 39,025 shares to own a total of 419,484 shares. FactSet recently exceeded Q4 earnings expectations with an EPS of $4.51 and revenue of $607.6 million, and also announced a $600 million share repurchase program and a quarterly dividend. Despite these positives, analyst ratings for FDS are generally cautious, with a consensus "Reduce" rating and an average price target of $313.17.

**4. ModivCare Completes Asset Transfer and Exit Financing**
- Source: TradingView â€” Track All Markets | 20251229T210849 | Neutral | Relevance: 64%
- ModivCare (MODVQ) completed significant restructuring on December 29, 2025, by transferring substantially all its assets to a buyer and securing an Exit Term Loan Credit Agreement. This financing will fund operations and plan distributions, replacing prior credit facilities and debtor-in-possession financing under its confirmed Chapter 11 plan. The new capital structure includes $400 million in exit term loans maturing in December 2030, ensuring post-emergence liquidity and aligning ownership with stakeholders.

**5. General Motors stock on track to beat auto rivals like Tesla, Ford in 2025**
- Source: New York Post | 20251229T235122 | Neutral | Relevance: 62%
- General Motors is set to finish 2025 as the leading US-traded automaker stock, outperforming competitors such as Ford, Tesla, and Stellantis. The stock has surged over 55% this year to a record high, driven by strong earnings and anticipation of favorable policies from the Trump administration. Analysts maintain high expectations, with UBS and Morgan Stanley raising price targets, as GM plans further stock buybacks due to perceived undervaluation.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 1, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | BMO Capital | $305 | $311 | -2% |
| 2025-12-19 | Goldman Sachs | $253 | $282 | -10% |
| 2025-12-19 | RBC Capital | $320 | $320 | 0% |
| 2025-12-19 | Stifel | $295 | $372 | -21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | BMO Capital | main | Market Perform |
| 2025-12-19 | Goldman Sachs | main | Sell |
| 2025-12-19 | RBC Capital | reit | Sector Perform |
| 2025-12-19 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 14 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Long-term trend broken: trading 21.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 25%). Analyst sentiment negative (4 target cuts vs 1 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.0B |
| Beta | 0.74 |
| 52W Range | $250.50 - $487.40 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 15.3 |
| Current P/E | 16.7 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 0.9% (minimal 5-day change). Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Below SMA200 (0.79x), long-term trend not supportive. RSI neutral at 55. Volume at 48% of 20MA suggests lack of conviction. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.94% (CS: 66) | Neutral |
| RSI_14 | 55.0 | Neutral |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 0.786x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $291.38
- **Stop Loss:** $275.78 (5.4% risk)
- **Target:** $306.98 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 52
- **Position Value:** $15,151.76
- **Portfolio %:** 15.15%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.36 | $4.51 | +3.5% |
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*